Background The use of blood biomarkers after mild traumatic brain injury (mTBI) has been
widely studied. We have identified eight unresolved issues related to the use of five …

Blood-based protein biomarkers have revolutionized several fields of medicine by enabling
molecular level diagnosis, as well as monitoring disease progression and treatment efficacy …

Accurate diagnosis for mild traumatic brain injury (mTBI) remains challenging, as prognosis
and return-to-play/work decisions are based largely on patient reports. Numerous …

The diagnosis of traumatic brain injury (TBI) in the acute setting is based on neurological
examination and neuroimaging tools such as CT scanning and MRI. However, CT scanning …

Background Blood biomarkers are valuable tools for elucidating complex cellular and
molecular mechanisms underlying traumatic brain injury (TBI). Profiling distinct classes of …

Traumatic brain injuries (TBIs) are caused by a hit to the head or a sudden acceleration/
deceleration movement of the head. Mild TBIs (mTBIs) and concussions are difficult to …

Blood biomarkers have been explored for their potential to provide objective measures in
the assessment of traumatic brain injury (TBI). However, it is not clear which biomarkers are …

Abstract HUIBREGTSE, ME, Bazarian, JJ, Shultz, SR, and Kawata K. The biological
significance and clinical utility of emerging blood biomarkers for traumatic brain injury …

During the past decade there has been an increasing recognition of the incidence of mild
traumatic brain injury (mTBI) and a better understanding of the subtle neurological and …

Mild traumatic brain injury (TBI) accounts for the vast majority of the nearly two million brain
injuries suffered in the United States each year. Mild TBI is commonly classified as …